Instruction for use: Decadron

Active substance: Dexamethasone

ATX Code H02AB02 Dexamethasone

Pharmacological group

Glucocorticosteroid

The nosological classification (ICD-10)

G93.6 Edema of the brain

Intraoperative cerebral edema, Cerebral edema, Post-traumatic swelling of the brain, Brain edema associated with radiation therapy, Brain edema associated with head trauma, Post-traumatic cerebral edema, Edema of the brain in poisoning

R11 Nausea and vomiting

Postoperative vomiting, Nausea, vomiting, Vomiting in the postoperative period, Vomiting drug, Vomiting on the background radiation therapy, Vomiting indomitable, Vomiting with radiation therapy, persistent vomiting, anacatharsis, Postoperative nausea, Vomiting during chemotherapy, Vomiting of central origin, Vomiting on the background of cytostatic chemotherapy, persistent hiccups, repeated vomiting

R57 Shock, not elsewhere classified

Obstructive shock

T78.4 Allergy, unspecified

Allergic reactions to insulin, Allergic reactions to insect stings, Allergic reactions similar to systemic lupus erythematosus, Allergic diseases, Allergic diseases of mucous membranes, Allergic diseases and conditions resulting from increased release of histamine, Allergic diseases of mucous membranes, Allergic symptoms, Allergic symptoms in the mucous membranes, Allergic reactions, Allergic reactions caused by insect bites, Allergic reactions, Allergic conditions, Allergic laryngeal edema, allergopathy, allergic conditions, Allergy, House dust allergy, Anaphylaxis, Cutaneous reactions to medications, Skin reaction to insect stings, Cosmetic allergy, Drug allergy, Acute allergic reaction, Laryngeal edema allergic genesis and background radiation, Food and drug allergy

T79.4 Traumatic shock

Hemorrhagic shock, Crush syndrome, hemorrhagic shock, postoperative shock, post-traumatic shock, traumatic shock, hemorrhagic shock and encephalopathy syndrome

T81.1 Shock during or after the procedure, not elsewhere classified

Operating shock, Postoperative shock, Operational shock

Composition and form of release

1 tablet contains dexamethasone 0.5 mg, in a pack of 100 pcs.

1 ml of solution for injection - dexamethasone phosphate 4 mg, in ampoules of 1 and 2 ml, in a package of 10 and 1 pc.

pharmachologic effect

Pharmacological action - anti-inflammatory, immunosuppressive.

Indications

Inflammatory and allergic diseases, nausea and vomiting caused by chemotherapeutic agents, shock and cerebral edema (injections).

Contraindications

Hypersensitivity, mycosis, vaccination with live viral vaccine.

Side effects

Violations of water-electrolyte balance, musculoskeletal system, gastrointestinal tract, endocrine and cardiovascular system; Dermatological, neurological, ophthalmic, metabolic and other disorders.

Interaction

It is possible to change the effects with simultaneous use with acetylsalicylic acid, phenytoin, phenobarbital, ephedrine, rifampin, indometacin, coumarin anticoagulants, diuretics.

Dosing and Administration

Inside, intravenously (intravenously), intramuscularly (intramuscularly), intraarticularly or intrabusally. Dosage and treatment are set individually according to the severity of the disease and the patient's reaction. In acute conditions and in urgent cases, the use of large doses (up to 20 mg) is permissible. In the future, dosage should be maintained at a minimum therapeutic level.

Storage Conditions

In the dark place.

Keep out of the reach of children.